Antoine Soetewey

Université Catholique de Louvain - UCLouvain | UCLouvain · Institute of Statistics, Biostatistics and Actuarial Sciences

Advancements in medicine and biostatistics have already resulted in a better access to insurance for people diagnosed with cancer. This materializes into the “right to be forgotten” adopted in several EU member states, granting access to insurance after a waiting period of at most 10 years starting at the end of the successful therapeutic protocol....

Introduction Un outil en biostatistique pour mesurer la différence d’espérance de vie ou de mortalité chez les patients cancéreux est le nombre d’années de vie perdues (YLL), quantifiant le nombre d’années de vie qu’une cohorte de patients a perdu par rapport à la population générale. L’analyse de survie est une classe de modèles avec deux états et...

The Massart (J Cancer Policy 15:70-71, 2018) testimonial illustrates the difficulties faced by patients having survived cancer to access mortgage insurance securing home loan. Data collected by national registries nevertheless suggest that excess mortality due to some types of cancer becomes moderate or even negligible after some waiting period. In...